AKT1 and glioblastoma: EVs derived from plasma and cerebrospinal fluid (CSF) of GBM patients have been demonstrated to enhance endothelial migration and proliferation of endothelial cells by activating the AKT/beta-catenin pathway shedding light into the functional role of proangiogenic EVs (40).